National Clinical Audit for Paediatric Diabetes

The overarching aim of the NPDA is the collection, analysis and effective reporting of robust comparative data on the quality of care and patient outcomes for young people being cared for in specialist paediatric diabetes units

United Kingdom-London: Miscellaneous health services

2016/S 160-290297

Contract notice

Services

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Healthcare Quality Improvement Partnership
6th Floor, 45 Moorfields
For the attention of: Judith Hughes
EC2Y 9AE London
United Kingdom
Telephone: +44 2079977311
E-mail: judith.hughes@hqip.org.uk

Internet address(es):

General address of the contracting authority: http://www.hqip.org.uk/

Address of the buyer profile: http://www.hqip.org.uk/

Further information can be obtained from: HQIP
45 Moorfields
EC2Y 9AE London
United Kingdom

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from:HQIP
45 Moorfields
EC2Y 9AE London
United Kingdom

Tenders or requests to participate must be sent to: HQIP
EC2Y 9AE London
United Kingdom

I.2)Type of the contracting authority

Body governed by public law

I.3)Main activity

Health

I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Welsh Government
Major Health Conditions Policy Team, Healthcare Policy Division, Directorate of Health, Policy, Department for Health and Social Services, Cathays Park
CF10 3NQ Cardiff
United Kingdom

Section II: Object of the contract

II.1)Description

II.1.1)Title attributed to the contract by the contracting authority:

HQIP NCA 2010 National Paediatric Diabetes Audit.

II.1.2)Type of contract and location of works, place of delivery or of performance

Services
Service category No 25: Health and social services
Main site or location of works, place of delivery or of performance: UK.
NUTS code

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves a public contract

II.1.4)Information on framework agreement

II.1.5)Short description of the contract or purchase(s)

The Healthcare Quality Improvement Partnership (HQIP), commissioning on behalf of NHS England and the health departments of the UK Devolved Nations who wish to participate, invites expressions of interest from suitable providers who are able to provide a national clinical audit of National Paediatric Diabetes Audit as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).
To achieve, this national clinical audits must effectively deliver both quality assurance and quality improvement functions at local and national levels. Building on the achievements of the current audit, HQIP will now be recommissioning the NPDA to continue to support quality improvement and quality assurance in paediatric diabetes care.
The national diabetes audit (NDA) was established in 2004 as a combined adult and paediatric audit. It was developed as part of the Diabetes National Service Framework (NSF) implementation plan to drive service improvement and monitor the impact of the NSF. In 2011 the adult and paediatric components were tendered separately and the NPDA was thus established to measure outcomes and NICE recommended care processes received by children in Paediatric Diabetes Units (PDUs) in England and Wales. It has, since 2011, been delivered by the Royal College of Paediatric and Child Health and has achieved 100% participation from all 177 units in England and Wales.
This contract is being tendered under the Public Contracts Regulation 2015 under an open procurement procedure and has been advertised in accordance with EU requirements.
Aims of this National Clinical Audit are:
The overarching aim of the NPDA is the collection, analysis and effective reporting of robust comparative data on the quality of care and patient outcomes for young people being cared for in specialist paediatric diabetes units in England and Wales. The audit should at its core be a mechanism to drive improvement within the NHS for the benefit of patients and those working to deliver care. Engagement with clinicians, patients and commissioners (both local and national) and regional networks is therefore essential in order to support improvements.
This audit programme is expected to:
a. Develop a robust, high-quality audit designed around key quality indicators likely to best support local and national quality improvement;
b. Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate;
c. Enable Improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, commissioner, MDT,possibly consultant or clinical team level and other levels of reporting;
d. Engage patients, carers and families in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit;
e. Consider the value and feasibility of linking data at an individual patient level to other relevant national data sets either from the outset or in the future, and plan for these linkages from the inception of the contract;
f. Ensure robust methodological and statistical input at all stages of the audit;
g. Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly;
h. Provide audit results in a timely, accessible and meaningful manner to support quality improvements, minimising the reporting delay and providing continual access to each unit for their own data;
i. Utilise strong and effective project and programme management to deliver audit outputs on time and within budget;
j. Close engagement with the adult NDA and to seek opportunities to align scope, methodology and outputs to optimise a whole pathway analysis of diabetes care and outcomes from pregnancy and childhood through to adulthood; and
k. Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups in order to drive improvements in services for patients.

II.1.6)Common procurement vocabulary (CPV)

85140000, 85100000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): no

II.1.8)Lots

This contract is divided into lots: no

II.1.9)Information about variants

Variants will be accepted: no

II.2)Quantity or scope of the contract

II.2.1)Total quantity or scope:

Estimated value excluding VAT: 981 000 GBP

II.2.2)Information about options

Options: no

II.2.3)Information about renewals

This contract is subject to renewal: yes
Number of possible renewals: 2

II.3)Duration of the contract or time limit for completion

Duration in months: 36 (from the award of the contract)

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract

III.1.1)Deposits and guarantees required:

As detailed in the ITT.

III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

As detailed in the ITT.

III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

As detailed in the ITT.

III.1.4)Other particular conditions

The performance of the contract is subject to particular conditions: yes
Description of particular conditions: As per acceptance of HQIP Standard Terms and Conditions of Contract as supplied with the ITT.

III.2)Conditions for participation

III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: As detailed in the ITT.

III.2.2)Economic and financial ability

Information and formalities necessary for evaluating if the requirements are met: As detailed in the ITT.
Minimum level(s) of standards possibly required: As detailed in the ITT.

III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
As detailed in the ITT.
Minimum level(s) of standards possibly required:
As detailed in the ITT.

III.2.4)Information about reserved contracts

III.3)Conditions specific to services contracts

III.3.1)Information about a particular profession

Execution of the service is reserved to a particular profession: no

III.3.2)Staff responsible for the execution of the service

Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: no

Section IV: Procedure

IV.1)Type of procedure

IV.1.1)Type of procedure

Open

IV.1.2)Limitations on the number of operators who will be invited to tender or to participate

IV.1.3)Reduction of the number of operators during the negotiation or dialogue

IV.2)Award criteria

IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document

IV.2.2)Information about electronic auction

An electronic auction will be used: no

IV.3)Administrative information

IV.3.1)File reference number attributed by the contracting authority:

HQIP NCA 2010

IV.3.2)Previous publication(s) concerning the same contract

IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document

Payable documents: no

IV.3.4)Time limit for receipt of tenders or requests to participate

29.9.2016 – 12:00

IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates

IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.

IV.3.7)Minimum time frame during which the tenderer must maintain the tender

in days: 120 (from the date stated for receipt of tender)

IV.3.8)Conditions for opening of tenders

Persons authorised to be present at the opening of tenders: no

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about European Union funds

The contract is related to a project and/or programme financed by European Union funds: no

VI.3)Additional information

This contract opportunity is being offered using e-procurement, please follow the attached link:

http://redirect.transaxions.com/events/AXCsE

Suppliers will need to complete the Supplier Registration Form (SRF) within the e-procurement system, if a supplier has already been approved on the S2C E-Procurement portal they do not need to complete the SRF again.

VI.4)Procedures for appeal

VI.4.1)Body responsible for appeal procedures

VI.4.2)Lodging of appeals

VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:

18.8.2016

Nursing and Domiciliary Care Services in Norfolk

Welsh Blood Service Archiving Service

NHS England South GP Services Plymouth

Prison Healthcare Services Tender